Skip to content

T Bil BR8307

by Randox Laboratories, Ltd.

Ref BR8307

T Bil BR8307 is a total bilirubin IVD (EU IVDD general IVD; FDA Class II; FDA product code JFM, Enzymatic Method, Bilirubin) made by Randox Laboratories, Ltd., registered in EUDAMED on 27 Oct 2026 (Basic UDI-DI B-05055273208306), cleared under FDA 510(k) K152344 on 28 Jan 2016 and listed in FDA GUDID since 16 Sep 2016 (UDI-DI 05055273208306), active as of 7 Nov 2026. One FDA recall is linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE IVDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

1 ongoing

This device is named in the recall

Documents

None, self-declared

Class I: no certifier involved

510(k) K152344

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-05055273208306 Basic UDI-DI 05055273208306UDI-DIDate27 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number05055273208306 UDI-DI Date16 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK152344 Date28 Jan 2016DecidedStatusActive

Official records

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-05055273208306 registered 27 Oct 2026 Active
  • FDA 510(k) K152344 decided 28 Jan 2016 Active
  • FDA GUDID UDI-DI 05055273208306 listed 16 Sep 2016 Listed

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Recalls

1 recall · 1 ongoing · FDA

    • Ongoing Z-0501-2024 FDA Class II initiated 11 Oct 2023

    Randox has had reports of elevated patient results using Plasma (lithium heparin) samples with Total Bilirubin reagent (TBil) Vanadate Oxidation Method.

Timeline

4 dated events

  1. Cleared FDA 510(k) K152344
  2. Listed FDA GUDID 05055273208306
  3. Recall initiated FDA recalls Z-0501-2024
  4. Registered EUDAMED B-05055273208306

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Total Bilirubin (T Bil) EUDAMED
T Bil GUDID
Generic name
Total bilirubin IVD, reagent
Model / Ref / Catalog
BR8307
Primary DI / UDI-DI
05055273208306
Basic UDI-DI
B-05055273208306
510(k) Number
FDA product code
JFM
EMDN code
W01010203 Bilirubin
GMDN term
Total bilirubin IVD, reagent
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
862.1110
EU registration type
Legacy device (under a directive)
EU market of registration
Northern Ireland
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under BILIRUBIN.

Other devices from Randox Laboratories, Ltd.

See all devices from Randox Laboratories, Ltd. →

Properties

  • Single use
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (17, all answered No)